ALPHAMEDIS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ALPHAMEDIS
Largest movements
- Receivables within one year -€34,444
down €34,444 (-3.2%), from €1.1m to €1.1m
of which Trade receivables: -€34,089
- Profit (loss) carried forward -€424,537
down €424,537 (-36.7%), from €1.2m to €732,311
- Trade debts +€278,107
up €278,107 (+51.6%), from €538,806 to €816,913
- Other debts +€100,000
new in 2026: €100,000
- Gross operating margin -€348,782
down €348,782 (-20.7%), from €1.7m to €1.3m
- Staff costs -€269,771
down €269,771 (-13.7%), from €2.0m to €1.7m
- Other operating charges -€114,996
down €114,996 (-79.1%), from €145,369 to €30,373
- Provisions -€17,459
down €17,459 (-92.9%), from €18,803 to €1,344
From the 2025 result to the 2026 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2025 and 2026 balance sheets and the 2026 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2025 | 2026 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,203,917 | €2,158,272 | -€45,645 | -2.1% |
| Fixed assets | 21/28 | €43,511 | €52,917 | +€9,406 | +21.6% |
| Tangible fixed assets | 22/27 | €27,461 | €36,867 | +€9,406 | +34.3% |
| Plant, machinery and equipment | 23 | €12,312 | €19,292 | +€6,980 | +56.7% |
| Furniture and vehicles | 24 | €9,310 | €15,916 | +€6,606 | +71.0% |
| Other tangible fixed assets | 26 | €5,838 | €1,659 | -€4,179 | -71.6% |
| Financial fixed assets | 28 | €16,050 | €16,050 | = | 0.0% |
| Current assets | 29/58 | €2,160,406 | €2,105,355 | -€55,051 | -2.5% |
| Stocks and contracts in progress | 3 | €538,130 | €547,108 | +€8,979 | +1.7% |
| Stocks | 30/36 | €538,130 | €547,108 | +€8,979 | +1.7% |
| Amounts receivable within one year | 40/41 | €1,091,464 | €1,057,020 | -€34,444 | -3.2% |
| Trade receivables | 40 | €1,090,797 | €1,056,708 | -€34,089 | -3.1% |
| Other amounts receivable | 41 | €667 | €312 | -€354 | -53.1% |
| Cash at bank and in hand | 54/58 | €508,479 | €489,398 | -€19,081 | -3.8% |
| Deferred charges and accrued income | 490/1 | €22,333 | €11,828 | -€10,505 | -47.0% |
| Total equity and liabilities | 10/49 | €2,203,917 | €2,158,272 | -€45,645 | -2.1% |
| Equity | 10/15 | €1,376,198 | €951,661 | -€424,537 | -30.8% |
| Contributions | 10/11 | €124,000 | €124,000 | = | 0.0% |
| Capital | 10 | €124,000 | €124,000 | = | 0.0% |
| Issued capital | 100 | €124,000 | €124,000 | = | 0.0% |
| Reserves | 13 | €95,350 | €95,350 | = | 0.0% |
| Non-distributable reserves | 130/1 | €14,938 | €14,938 | = | 0.0% |
| Legal reserve | 130 | €14,938 | €14,938 | = | 0.0% |
| Tax-exempt reserves | 132 | €37,500 | €37,500 | = | 0.0% |
| Distributable reserves | 133 | €42,912 | €42,912 | = | 0.0% |
| Profit (loss) carried forward | 14 | €1,156,848 | €732,311 | -€424,537 | -36.7% |
| Provisions and deferred taxes | 16 | €18,803 | €20,147 | +€1,344 | +7.1% |
| Provisions for liabilities and charges | 160/5 | €18,803 | €20,147 | +€1,344 | +7.1% |
| Pensions and similar obligations | 160 | €18,803 | €20,147 | +€1,344 | +7.1% |
| Amounts payable | 17/49 | €808,916 | €1,186,464 | +€377,548 | +46.7% |
| Amounts payable within one year | 42/48 | €776,949 | €1,148,409 | +€371,460 | +47.8% |
| Trade debts | 44 | €538,806 | €816,913 | +€278,107 | +51.6% |
| Suppliers | 440/4 | €538,806 | €816,913 | +€278,107 | +51.6% |
| Taxes, remuneration and social security | 45 | €238,143 | €231,497 | -€6,647 | -2.8% |
| Taxes | 450/3 | €3,475 | €11,185 | +€7,709 | +221.8% |
| Remuneration and social security | 454/9 | €234,668 | €220,312 | -€14,356 | -6.1% |
| Other amounts payable | 47/48 | - | €100,000 | +€100,000 | |
| Accrued charges and deferred income | 492/3 | €31,967 | €38,054 | +€6,087 | +19.0% |
| Non-recurring operating income | 76A | €0 | - | = | |
| Remuneration, social security and pensions | 62 | €1,967,106 | €1,697,334 | -€269,771 | -13.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €23,187 | €18,858 | -€4,329 | -18.7% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€5,743 | -€10,453 | -€4,710 | -82.0% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €18,803 | €1,344 | -€17,459 | -92.9% |
| Other operating charges | 640/8 | €145,369 | €30,373 | -€114,996 | -79.1% |
| Gross operating margin | 9900 | €1,685,937 | €1,337,155 | -€348,782 | -20.7% |
| Operating profit (loss) | 9901 | -€462,784 | -€400,302 | +€62,482 | +13.5% |
| Financial income | 75/76B | €437 | €457 | +€20 | +4.5% |
| Recurring financial income | 75 | €437 | €457 | +€20 | +4.5% |
| Financial charges | 65/66B | €16,029 | €20,342 | +€4,314 | +26.9% |
| Recurring financial charges | 65 | €16,029 | €20,342 | +€4,314 | +26.9% |
| Profit (loss) for the period before taxes | 9903 | -€478,376 | -€420,187 | +€58,189 | +12.2% |
| Income taxes | 67/77 | €4,262 | €4,350 | +€88 | +2.1% |
| Profit (loss) for the period | 9904 | -€482,638 | -€424,537 | +€58,101 | +12.0% |
| Profit (loss) for the period to be appropriated | 9905 | -€482,638 | -€424,537 | +€58,101 | +12.0% |
Source: filed annual accounts (NBB), financial years ended 31 March 2025 and 31 March 2026. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.